dc.creatorGatica, Rodrigo [Univ Mayor, Fac Ciencias, Escuela Vet]
dc.creatorWestermeier, Francisco
dc.creatorHolyoak, Todd
dc.creatorAsenjo, Joel L.
dc.creatorNualart, Francisco
dc.creatorBurbulis, Ian
dc.creatorBertinat, Romina
dc.date.accessioned2020-04-12T14:11:55Z
dc.date.accessioned2020-04-14T15:37:58Z
dc.date.accessioned2022-10-18T18:41:40Z
dc.date.available2020-04-12T14:11:55Z
dc.date.available2020-04-14T15:37:58Z
dc.date.available2022-10-18T18:41:40Z
dc.date.created2020-04-12T14:11:55Z
dc.date.created2020-04-14T15:37:58Z
dc.date.issued2019
dc.identifierWestermeier, F., Holyoak, T., Asenjo, J. L., Gatica, R., Nualart, F., Burbulis, I., & Bertinat, R. (2019). Gluconeogenic Enzymes in β-Cells: Pharmacological Targets for Improving Insulin Secretion. Trends in Endocrinology & Metabolism.
dc.identifier1043-2760
dc.identifier1879-3061
dc.identifierhttps://doi.org/10.1016/j.tem.2019.05.004
dc.identifierhttp://repositorio.umayor.cl/xmlui/handle/sibum/6607
dc.identifierDOI: 10.1016/j.tem.2019.05.004
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4454450
dc.description.abstractPancreatic beta-cells express the gluconeogenic enzymes glucose 6-phosphatase (G6Pase), fructose 1,6-bisphosphatase (FBP), and phosphoenolpyruvate (PEP) carboxykinase (PCK), which modulate glucose-stimulated insulin secretion (GSIS) through their ability to reverse otherwise irreversible glycolytic steps. Here, we review current knowledge about the expression and regulation of these enzymes in the context of manipulating them to improve insulin secretion in diabetics. Because the regulation of gluconeogenic enzymes in beta-cells is so poorly understood, we propose novel research avenues to study these enzymes as modulators of insulin secretion and beta-cell dysfunction, with especial attention to FBP, which constitutes an attractive target with an inhibitor under clinical evaluation at present.
dc.languageen
dc.publisherELSEVIER SCIENCE LONDON
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceTrends Endocrinol. Metab., AGO, 2019. 30(8): p. 520-531
dc.subjectEndocrinology & Metabolism
dc.titleGluconeogenic Enzymes in beta-Cells: Pharmacological Targets for Improving Insulin Secretion
dc.typeOtros


Este ítem pertenece a la siguiente institución